Internal Medicine

ASCO 2022

Questions discussed in this category

What are your top takeaways in Thoracic Cancers from ASCO 2022?

What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice?

6 Answers available

Papers discussed in this category

N Engl J Med, 2022 Jun 03

Adagrasib in Non-Small-Cell Lung Cancer Harboring a Mutation.

J Clin Oncol, 2022 Jun 03

Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MAP S1800A.

Related Topics in Internal Medicine